Universe · entity
Fairmount Funds Management LLC
Institutional manager (13F) · CIK 1802528
13F holdings · as of 2026-03-31 · top 12 · reported portfolio $1.4B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | DAMORA THERAPEUTICS INC | $226M | 8,713,000 |
| 2 | DIANTHUS THERAPEUTICS INC | $213M | 2,537,191 |
| 3 | COGENT BIOSCIENCES INC | $212M | 5,503,418 |
| 4 | SPYRE THERAPEUTICS INC | $203M | 4,018,101 |
| 5 | ORUKA THERAPEUTICS INC | $182M | 3,705,262 |
| 6 | VIRIDIAN THERAPEUTICS INC | $77M | 3,914,458 |
| 7 | ENLIVEN THERAPEUTICS INC | $73M | 1,855,644 |
| 8 | JADE BIOSCIENCES INC | $64M | 4,553,494 |
| 9 | CRESCENT BIOPHARMA INC. | $50M | 2,747,866 |
| 10 | ZENAS BIOPHARMA INC | $46M | 2,359,025 |
| 11 | APOGEE THERAPEUTICS INC | $25M | 298,647 |
| 12 | INHIBIKASE THERAPEUTICS INC | $14M | 8,625,000 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.